Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Industry News

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

March 17, 2016

News Industry News

Xeltis Completed Second Feasibility Clinical Trial on Bioabsorbable Cardiovascular Device Technology

November 09, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Industry News

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

July 21, 2014

News Industry News

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

July 17, 2014

News Industry News

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

June 04, 2014

News Industry News

Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System

March 12, 2014

News Industry News

Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections

January 27, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Industry News

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

July 10, 2013

News Industry News

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

February 11, 2013

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

May 17, 2012

News Industry News

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 09, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

Advertisement

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

Xeltis Completed Second Feasibility Clinical Trial on Bioabsorbable Cardiovascular Device Technology

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

BIOTRONIK Announces New Study Evaluating Efficacy of Combined Pulsar-18 Stent and Passeo-18 Lux Balloon in Treating SFA Disease

Medtronic Expands Availability of Market-Leading Aortic & Peripheral Solutions to U.S. Market

Boston Scientific Receives CE Mark Approval for REBEL™ Platinum Chromium Coronary Stent System

Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content